The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR Trial
Author:
Silvio Danese,Martina Goetsch,Laurent Peyrin-Biroulet,Andres J. Yarur,Marla Dubinsky,David T. Rubin,Brian G. Feagan,Geert D’Haens,Filip Baert,Krisztina Lazin,Guibao Gu,Jin Yu,Nervin Lawendy,Chuanbo Zang,Wenjin Wang,Sujatha Menon,Ernest H. Law et al.
Publication:
Clinical Gastroenterology and Hepatology
Date:
Available online 4 June 2026
© 2026 Pfizer Inc and Authors. Published by Elsevier Inc. on behalf of American Gastroenterological Association Institute.